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Abstract 
Background: In the United States, an estimated 23 million cases of norovirus (NoV) are 
reported each year, and although mortality is low, the morbidity and economic impact are 
substantial.   
 
Methods: RT-PCR and sequencing were used for identification of NoV genotypes 
obtained from outbreak and sporadic cases. RT Quant PCR was used to determine the 
viral load in fecal specimens.  In order to rule out bacterial infection as the cause for 
acute gastroenteritis (AGE), bacterial culture for Salmonella, E.coli O157, Shigella, 
Campylobacter and Clostridium difficile was performed by standard laboratory 
procedures.  The duration of NV shedding was investigated with longitudinal sampling in 
the sporadic cases and an evaluation of the association between viral load and days since 
clinical onset in the outbreak-associated cases. 
 
Results: We describe the epidemiology and strain identification for NoV circulating in 
Michigan during 2007-8 in concurrent sporadic and outbreak-associated cases.    In 2007-
8, 138 norovirus outbreaks (3,437 cases) were reported to the MDCH.  Among the 47 
outbreak specimens sequenced, GI was identified in 14 (29.8%) and GII in 33 (70.2%).  
The predominant type was GII.4, found in 23 of the 33 (69.6%) GII specimens.  The 
statistical analysis of outbreak-associated cases showed that neither NoV type nor 
number of days post-onset were associated with NoV log concentration.  Among the 
sporadic cases, the repeated measures analysis of variance showed that NoV type (I or II) 
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was not associated with log titer (P = 0.90), but that the number of weeks post-onset was 
statistically associated with declining log titer at p = 0.0005. 
 
Conclusion: We found no predominant strain difference between concurrent sporadic 
and outbreak-associated cases.  Prevalent strains of NoV were shed in high concentration 
for at least two weeks past disease onset, suggesting that current public health 
recommendations for 2-3 days home isolation following clinical recovery may need to be 
lengthened. 
 
 Keywords: public health, norovirus, epidemiology 
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Background 
Noroviruses (NoVs) are the leading cause of acute gastroenteritis (AGE) in adults, 
causing numerous outbreaks worldwide (Frankhauser et al, 2002; Siebenga et al, 2009; 
Patel et al, 2009).  In the United States, an estimated 23 million cases of NoV occur 
annually. Although mortality is low, the morbidity and economic impact are substantial 
(Mead et al, 1999; Marks et al, 2003). Cases are most commonly attributed to 
contaminated food and/or drinking water, exposure to aerosolized feces or vomitus, direct 
or indirect oral contact with contaminated surfaces and direct fecal-oral transmission 
(Harrington et al, 2004).  
 
Noroviruses are a group of non-cultivable, genetically diverse single-stranded RNA 
viruses belonging to the family Caliciviridae. They are classified into five genogroups 
based on the sequences of the RNA polymerase and capsid region of the genome. The 
genomes have three open reading frames (ORF). ORF1 encodes the nonstructural 
polyprotein, while ORF2 encodes the capsid protein and ORF3 encodes a putative minor 
structural protein (Symes et al, 2007). Genogroups I, II, and IV are associated with 
infections in humans. Currently, 32 genetic clusters have been identified (8 from GI; 19 
from GII; 2 from GIII; 2 from GIV and  one from GV), demonstrating a high degree of 
genomic diversity among NV (Ando, Noel & Frankhauser, 2000; Green et al, 2000; 
Wang et al, 2006; Martella et al, 2007).  
 
In the U.S. approximately 50% of outbreak cases of waterborne and food-borne enteric 
diseases are due to NoV, but there is less information about sporadic cases of NoV 
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related AGE. (CDC, 2001, 2003; Monroe, 2005).  Information regarding sporadic NoV is 
lacking due to the difficulty in obtaining fecal specimens from patients sufficiently early 
in the clinical course of their illness, and also because specimens for laboratory analysis 
are rarely obtained in the absence of an outbreak.  In Michigan, the state health 
department laboratory normally only accepts clinical specimens for NoV diagnosis from 
outbreaks but not from sporadic cases. 
 
It may be possible that different norovirus strains predominate among the sporadic NoV 
cases, and that patterns of disease progression and viral shedding may be very different 
among these sporadic cases compared with cases from recognized outbreaks. 
Alternatively, sporadic NoV cases may result from low dose exposures to the same 
strains responsible for NoV outbreaks.  Perhaps persons who have become ill by 
exposure to low doses of infectious particles may have a very different shedding pattern 
from individuals whose immune systems have been affected by massive doses of 
infectious particles as occurs in some outbreaks.   
 
Most NoV outbreaks subside within 5-6 days, and the duration of symptoms in 
individuals is usually 48-72 hours (CDC, 2006).  Health departments generally 
recommend that food handlers and health care providers stay at home for 2-3 days after 
clinical recovery.  However, a recent report of an intentional NoV challenge showed that 
some people shed virus for as long as 2 or 3 weeks after clinical recovery, but it is 
unknown what percentage of naturally infected people will shed for these extended 
periods (Okhuysen et al, 1995; CDC, 2005; Atmar et al, 2008; Siebenga et al, 2008; 
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Kirkwood & Steitberg, 2008). Prolonged shedding of virus could increase the spread of 
NoV infection, thus it is possible that public health recommendations should be amended 
to increase the duration of home isolation of convalescing cases to reflect this prolonged 
shedding period. 
 
Norovirus is one of the only enteric pathogen for which human challenge studies are 
ethically possible.  While very helpful in elucidating NoV pathogenesis, these challenge 
studies were done with NoV from stored fecal specimens rather than from currently 
circulating strains. Challenge strains were derived from specimens collected before 1994 
and from 1993-1996, respectively (Atmar et al, 2008; Phillips et al, 2009).  Challenge 
studies may differ from naturally acquired infection in the challenge dose, method of 
transmission and the age and health status of the volunteers; challenge studies need to 
exclude volunteers with any underlying illnesses.  It needs to be determined to what 
extent evidence of extended duration NoV shedding obtained from challenge studies can 
be generalized to naturally acquired infections. 
 
Our objective in this study was to describe the epidemiology and strain identification for 
NoV circulating in Michigan during 2007-8 in concurrent sporadic and outbreak-
associated NoV cases.  We also sought to evaluate the duration of convalescent NoV 
shedding. 
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Materials and Methods 
Outbreak Surveillance for NV in Michigan:  The policy of the Michigan Department 
of Community Health (MDCH) is to conduct outbreak-associated NoV testing on fecal 
specimens from no more than 6 people per outbreak.  Specimens are routinely classified 
by PCR as negative or positive for viral RNA, and strains are typically classified only as 
GI or GII.  In 2008, a descriptive epidemiologic analysis was conducted for each 
outbreak setting for which a sufficient number of specimens had been obtained.  Forty-
seven NoV-positive specimens from outbreak-associated cases were selected for 
sequencing and quantitative assessment.  Selection of specimens was based on the 
availability of individual onset dates and a sufficient quantity of specimen available for 
further laboratory testing. Specimens came from 14 outbreaks in 12 Michigan counties 
during 2007-08.  These 47 specimens were analyzed using the quantitative NoV PCR 
assay described below.  
 
Sporadic AGE Cases:  Fecal specimens were obtained from 18 volunteers with AGE 
whose symptoms were compatible with norovirus infection and who were not part of any 
recognizable outbreak. Volunteers included some university students, but most were 
referred to our study by participating local outpatient clinics who assisted us in 
distributing sampling supplies to persons they suspected of having NV infection. In 
addition to not being part of an outbreak of more than 2 associated cases, our sporadic 
cases were over 18 years of age, had no more than a low-grade fever, did not have bloody 
diarrhea, and did not suffer from recurring episodes of gastroenteritis.  Onset fecal 
specimens were verified as negative for Salmonella, E.coli O157, Shigella, 
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Campylobacter and Clostridium difficile by standard MDCH laboratory procedures 
(MacFaddin, 1980; Bopp, Brenner & Fields, 2003; Nachamkin, 2003). Food service and 
health care workers were not included in this study because identification of a reportable 
enteric pathogen may have required them to be excluded from their workplace pending 
negative stool culture results.  Study subjects were from local primary care clinics (2), 
community volunteers (15), and a nursing home (1).  Stool specimens were requested at 
the onset of vomiting or diarrhea, 1 week after onset and 2 weeks after onset.  Cases were 
paid an honorarium for participation, as approved by the IRB Committees at both MSU 
and MDCH. 
The sporadic cases were screened to verify the absence of Salmonella, Campylobacter, 
Clostridium difficile, Shigella, and E.coli O157.  The initial specimens were submitted in 
Cary-Blair transport media for bacterial culture. Stool samples were inoculated onto 
MacConkey (MAC), MacConkey Sorbitol, MacConkey Sorbitol with cefizime and 
tellurite (CT-SMAC), and Hektoen Enteric (HEK) plates and a tetrathionate enrichment 
broth and incubated aerobically at 35˚C for 48 hrs. To demonstrate Clostridium difficile, 
an aliquot of stool was plated directly to a cycloserine cefoxitin fructose agar plate 
(CCFA) and incubated anerobically.  An additional aliquot was treated with ethanol for 
one hour at room temperature and then plated on an anerobic blood agar plate.  The plates 
were held for 96 hours before being discarded as negative.  A Campylobacter blood agar 
plate was also inoculated and incubated microaerophilically at 42˚C for 72 hrs. The 
tetrathionate broth was subcultured to a MAC and HEK after 24 hours incubation.  All 
plates were read at 24-hour intervals, but held 48 hours before being reported as negative. 
Suspect organisms were identified using Gram’s stain, colony morphology and 
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conventional biochemical tests (MacFaddin, 1980; Bopp, Brenner & Fields, 2003; 
Nachamkin, 2003).  
 
RNA extraction, RT PCR, sequencing and RT Quant PCR. 
Stool specimens from both sporadic and outbreak-associated cases were suspended in 
sterile water (10 percent weight/volume). Specimens were centrifuged at 13000xg and the 
resulting supernatant was filtered through a 0.45 µM filter. NV RNA was extracted from 
200 µl of the filtrate using QIAGEN QIAmp viral RNA mini kit (QIAGEN, Valencia, 
CA) according to the manufacturer’s protocol.  5 µl of the eluted viral RNA suspension 
was used for RT PCR. 
RT-PCR was performed using established primers and probes Cog 1F, Cog 1R, Ring 1A, 
Ring 1B, Cog 2F, Cog 2R and Ring 2 for region B as described previously (Kageyama et 
al, 2003). 
Four primers that target the 3’-end of the RNA polymerase gene (region B) were used to 
detect strains of GI and GII genogroups. Primers, MON 432, MON 434 for detecting GI 
strains and MON 431, MON 433 for GII strains, yielding a 213 base pair amplicon 
(Anderson et al, 2001). 
To analyze sequence information the biometrics applied MATH system was used. 
Sequences were blasted into a local database to provide similarities and dendrograms.   
The RT Quant PCR was performed using the Roche LightCycler 1.5 with 4.0 analysis 
software with the following modifications of the procedure described above:  GI probes 
(Ring1a and Ring1b) were used at 400nm each and the volume of H2O in reaction mix 
was adjusted to allow for 5 µl of RNA (Trujillo et al, 2006).  Standard curves for NV 
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quantification were generated using serial dilutions of GI and/or GII norovirus transcripts 
obtained from CDC and representing ORF1, 2 and 3 of the 3’ region of G1.4 and GII.4 
respectively.   
 
Statistical analysis: The outbreak-associated NoV concentrations were analyzed in a 
general linear model (SAS 9.1) with log concentration as the dependent variable and days 
post-onset and NoV group (I or II) as independent variables. The sporadic case data were 
analyzed as a mixed model with log titer as the repeated dependent variable and NoV 
type as the sole independent variable.      
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Results 
Michigan NV Surveillance:  In 2008, 138 norovirus outbreaks (3,437 cases) were 
reported to the MDCH (Figure 1).  Of these, 30 were confirmed by laboratory analysis of 
2 or more collected specimens; 26 (87%) outbreaks were related to GII and 4 (13%) 
outbreaks were related to GI.  The remaining 108 outbreaks were judged to have been 
NoV based on clinical and epidemiologic presentation.  Most outbreaks (n=63) were 
associated with healthcare services, followed by restaurants (26), schools (25) and other 
settings (24).  
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Figure 1  
 
Reported Michigan Norovirus Outbreaks, 2007-2008  
 
 
 
Outbreak-associated Cases: 
Among the 47 outbreak specimens sequenced, GI was identified in 14 (29.8%) and GII in 
33 (70.2%) (Table1).  The predominant type was GII.4, found in 23 of the 33 GII 
specimens (69.6%).  The statistical analysis showed that neither NV type (I or II) nor 
days post-onset were associated with RNA log concentration, at p > 0.8 in both instances. 
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Table 1  
 
Sequencing and Quantitative Assessment of Selected Michigan Norovirus Outbreak-
associated Cases  
 
County Date Genotype Specimen Number 
Concentration 
/ gram feces 
Days 
Post 
Onset 
 
Log 
Concentration / 
gram feces 
Eaton 10/27/07 SaitamaT13-JPN_GI.2 
O-1A 2.07 x 108 0.5 8.3 
O-1B 1.12 x 109 3 9.0 
O-1C 1.72 x 109 2 9.2 
O-1D 6.81 x 107 0.5 7.8 
O-1E 1.14 x 106 0.5 6.1 
O-1F 7.29 x 108 4 8.9 
Berrien 11/13/07 
Lit-
USA94_GI.3
B 
O-2A 9.94 x 108 2 9.0 
O-2B 6.02 x 1010 7 10.8 
O-2C 4.97 x 108 6 8.7 
O-2D 2.61 x 109 3 9.4 
O-2E 4.94 x 1010 3 10.7 
Jackson 
 
12/13/07 
 
SaitamaT13-
JPN_GI.2 
 
O-3A 
 
1.31 x 1010 1 10.1 
 
Calhoun 12/18/07 FMHill-USA_GII.4 
O-4A 9.76 x 107 4 8.0 
O-4B 1.58 x 108 5 8.2 
O-4C 1.14 x 108 4 8.1 
Kalamaz
oo 
12/20/07 Minerva2006B (GII.4) 
O-5A 3.76 x 108 1 8.6 
O-5B 3.17 x 108 2 8.5 
O-5C 3.67 x 1010 1 10.6 
Genesee 12/21/07 SaitamaT13-JPN_GI.2 
O-6A 1.33 x 109 2 9.1 
O-6B 6.27 x 106 5 6.8 
Kent 1/11/08 FMHill-USA_GII.4 
O-7A 7.77 x 108 6 8.9 
O-7B 1.83 x 109 6 9.3 
O-7C 2.08 x 109 6 9.3 
O-7D 4.70 x 108 5 8.7 
Genesee 2/15/08 
GN273-
USA94_GII.
7 
O-8A 2.70 x 107 1 7.4 
O-8B* 1.53 x 10 7 3 7.2 
O-8C 6.57 x 108 1 8.8 
Mason 2/19/08 FMHill-USA_GII.4 
O-9A 1.84 x 109 5 9.3 
O-9B 6.33 x 1011 5 11.8 
O-9C 2.33 x 108 1 8.4 
O-9D 2.37 x 108 2 8.4 
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O-9E 7.53 x 109 4 9.9 
O-9F 1.50 x 108 4 8.2 
Genesee 3/7/08 
SU1-
JPN_GII.12 O-10A 8.67 x 10
9
 0.5 9.9 
Menomi
nee 
3/19/08 FMHill-USA_GII.4 
O-11A 6.45 x 108 3 8.8 
O-11B 1.71 x 109 3 9.2 
Mecosta 
(DHD#1
0) 
3/20/08 FMHill-USA_GII.4 
O-12A 6.69 x 1010 1 10.8 
O-12B 3.63 x 109 0.5 9.6 
O-12C 3.19 x 108 1 8.5 
Wayne 4/1/08 
IDA-
USA96_GII.
8B 
O-13A 5.33 x 107 8 7.7 
O-13B 5.74 x 108 6 8.8 
O-13C 5.46 x 108 6 8.7 
O-13D 9.10 x 107 6 8.0 
O-13E 3.98 x 107 7 7.6 
O-13F 1.71 x 108 5 8.2 
Western 
UP - 
Gogebic 
5/15/08 FMHill-USA_GII.4 
 
O-14A 
 
2.71 x 108 2 8.4 
 
O-14B 
 
1.49 x 108 4 
 
8.2 
 
 
* Specimen did not sequence 
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Figure 2 
 
Concentration of Norovirus GI Particles per gram of Feces in Outbreak-associated 
Cases 
 
 
Y=0.193x+8.306                                                                                                   R2=0.091     
 
Convalescent shedding was observed in both GI and GII genotypes (Figures 2, 3). Our 
analysis of the outbreak-associated cases showed that viral shedding was detected in 
specimens collected as long as 8 days post-onset.  The finding that days post-onset was 
not statistically associated with viral load means that we did not see any decrease in 
shedding in the days after disease onset.  No information was available on duration of 
illness for these cases, but since NoV symptoms normally last 12-60 hours (CDC, 2001) 
it is likely that shedding continued several days past clinical recovery.   
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Concentration of Norovirus GII particles per gram of Feces in Outbreak
Cases 
 
Y=-0.088x+9.102                                                                                         R
 
Sporadic Cases:   
Culture results for Salmonella, Shigella, Campylobacter,
were negative for all sporadic cases. Ten of the 18 sporadic cases of AGE were positive 
for norovirus (Table 2). Specimens at onset were collected a mean of 1.2 days (range 0
days) after the first manifestation of diarrhea or vomiting. Norovirus GI were detected in 
3/10 (30%) and GII sequences were detected in 7/10 (70%) of cases.  Strain GII.4 was 
predominant, having been found in 4/7 (57%) of the GII cases.   Duration of illness
mean of 1.7 days (range 1 to 2) for the 7 cases where this information was available. The 
repeated measures analysis of variance showed that NoV type (I or II) was not associated 
-2008 
39 Volume 5, Issue 1, 2011
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-3 
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with RNA log titer (P=0.90) and that the number of weeks post onset of stool collection 
was statistically associated with declining RNA log titer at p=0.0005.  
 
Table 2 
 
Sequencing and Quantitative Assessment of Michigan Sporadic Norovirus Cases 
 
STUDY 
NUMBER GENOTYPE AGE GENDER ONSET 
~ 1 WK 
POST 
ONSET* 
~ 2 WK 
POST 
ONSET* 
S-11 BerlinBA-DEU_GI.4 57 M 
8.73 x 
109 1.04 x 10
7
 
1.93 x 
105 
S-12 BerlinBA-DEU_GI.4 56 F 
4.95 x 
108 1.04 x 10
6 1.34 x 
107 
S-104 GII.14_0732OH
_USA00 19 F 
1.20 x 
108 1.13 x 10
7
 
1.37 x 
106 
S-111 GII.4_FMHill_USA 49 F 
6.85x 
1010 5.99 x 10
8
 
1.12 x 
107 
S-112 GII.6_FLO_USA93 25 F 
8.02 x 
108 
≤3.86 x 
104 
≤3.86 x 
104 
S-113 GII.4_FMHill_USA 24 F 
1.28 x 
106 3.68 x 10
6
 
1.00 x 
106 
S-116 GI.3B-LR316_USA94 31 F 
7.29 x 
108 1.47 x 10
6
 
≤3.86 x 
104 
S-121 GII.4_FMHill_USA 50 F 
1.61 x 
109 
≤3.86 x 
104 
1.20 x 
107 
S-123 682_USA_GII.2 37 F 2.39 x 107 
≤3.86 x 
104 
≤3.86 x 
104 
S-124 GII.4_FMHill_USA 54 F 
1.08 x 
109 4.85 x 10
6
 
6.33 x 
1010 
 
*Concentration of NoV particles per gm feces at onset and 1 and 2 week post-onset. 
Specimens with concentrations listed as ≤3.86 x 104 did not amplify, and therefore 
this concentration is a minimum level of detection for the analysis and indicates 
that there were less than 64 transcripts (target sequences) for amplification in the 
5 µl sample.  
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Figure 4  
 
Concentration of Norovirus RNA Versus the Number of Days Post Onset of Specimen 
Collection for 10 Michigan Sporadic Cases.  
 
 
 
The issue of shedding duration is better addressed in our longitudinal database of 
sporadic NoV cases where specimens were collected from each person at 0, 1 and 2 
weeks post onset.  A downward sloping trend was detected for all but one case, and no 
significant difference in slope was seen between GI and GII strains (Figure 4).  While 
showing a statistically decreasing trend in viral load, titers of log 4 to10 were still being 
shed after 2 weeks. 
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Figure 5  
Phylogenetic Tree of Sporadic (S) and Outbreak-associated Cases (O) Based on 
Similarity to CDC Reference Strains. 
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We saw no distinctive strain differences between the sporadic and outbreak-associated 
NoV cases (Figure 5). Our findings agree with other reports that both GI and GII were 
circulating in Michigan and other U.S. states during 2008 (CDC, 2009). 
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Discussion 
Duration of Shedding: 
Our study of outbreak-associated and sporadic cases showed that viral shedding was 
observed in the specimens obtained up to 8 days post-onset and after 2 weeks, 
respectively. As such this finding is inconsistent with the theory that shedding rapidly 
subsides within a couple of days of disease onset. 
 
Determining the duration of shedding is of paramount importance in establishing public 
health policy regarding the prevention of transmission from NoV convalescent carriers. 
Public health isolation precautions may need to be extended beyond 2-3 days post 
recovery given the reportedly small infectious dose of < 100 NoV particles, the high 
environmental stability, and the current information regarding the lengthy and high-titer 
NoV convalescent shedding of NoV (Kapikian, Estes & Chanock, 1996; LeBaron et al, 
1990; CDC, 2003; Widdowson et al, 2005).   
 
However, it has been suggested that some post infection detection may be non-infectious 
soluble viral antigen without public health significance (CDC,2001).  Recent studies 
show that NoV genome can survive in water at 40, 250 and -200C for up to 2 months. 
Viral degradation was lower at 40 and -200C compared to 250C. Complete degradation of 
the genome was observed after 100 days (Ngazoa, Fliss & Jean, 2008).  Infectivity 
studies are needed to determine how much of the shedding from a convalescent carrier is 
infectious, however, such studies are problematic for a disease agent without an 
established animal model. 
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Norovirus infection is somewhat unique among etiologies of food-borne disease in that 
the benign nature of the disease allows researchers to purposefully challenge human 
volunteers in order to study the disease syndrome.  Only one NoV strain was used for 
each challenge study, but this may not have been the strain that was currently circulating 
among the human population. Persons made ill by naturally acquired infectious particles 
at low doses may have very different shedding patterns from individuals whose immune 
systems were overwhelmed by massive doses of infectious particles. Additionally, human 
volunteers for challenge studies cannot ethically include the very young, old and 
chronically ill (Atmar et al, 2008). Challenge volunteers, who are institutionalized for the 
duration of the challenge study, could have a very different standard of supportive care 
from self-treated cases occurring in the community.  For all these reasons, field studies 
are still necessary for studying the epidemiology and ecology of sporadic and outbreak- 
associated NoV cases under natural conditions of exposure, transmission and host 
susceptibility.   
 
The lowest infectious doses for norovirus are estimated to be 10 to 100 virus particles 
(FDA, 2007). Recent studies showed that the infectious dose depended on the genetics of 
the volunteers; 50 to 62% of the volunteers who had an epithelial binding gene (Se+), 
developed diarrhea when they were given doses from 104 to 108 viral particles and 
whereas volunteers who did not have the gene (S-) remained well with doses up to 108 
viral particles (Lindesmith et al, 2003; Hutson et al, 2005).  Also, the viral RNA load of 
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GII was found to be 100-fold higher than that of GI in fecal specimens of patients with 
norovirus-associated gastroenteritis (Chan et al, 2006).  
 
In conclusion, we found no dramatic strain differences between sporadic and outbreak-
associated cases of NoV.  The prevalent strains of NoV in both the sporadic and 
outbreak-associated cases were shed in high concentration for at least two weeks past 
disease onset, suggesting that current public health recommendations regarding hygienic 
precautions for convalescent carriers may need to be re-evaluated. 
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